Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
gestalt2's Profile
Displaying 601-650 of 810 result(s).
CYDY CytoDyn Inc
04/04/2020 1:07:27 PM
We also don’t know if more than t
CYDY CytoDyn Inc
04/04/2020 8:20:34 AM
You are correct, the original drug (3)
CYDY CytoDyn Inc
04/02/2020 6:27:10 PM
I heard the opposite, Dr Patterson
CYDY CytoDyn Inc
04/02/2020 2:40:12 PM
Wow is right - this is a stunning u (1)
CYDY CytoDyn Inc
04/02/2020 8:13:46 AM
It was 3/30 when they PR’d the 3 (3)
CYDY CytoDyn Inc
03/30/2020 12:16:41 PM
Should have given the deal that Dr (2)
CYDY CytoDyn Inc
03/30/2020 11:55:35 AM
It is interesting, however I rememb
CYDY CytoDyn Inc
03/30/2020 10:53:38 AM
Kind of interesting, a little light (1)
CYDY CytoDyn Inc
03/28/2020 2:26:57 PM
I guess we can call that an side ef (5)
CYDY CytoDyn Inc
03/28/2020 2:17:20 PM
With this drug, it is hard to imagi (3)
CYDY CytoDyn Inc
03/28/2020 1:39:54 PM
It is so strange that a drug design (3)
CYDY CytoDyn Inc
03/27/2020 8:23:32 AM
Could not put it better than that, (5)
CYDY CytoDyn Inc
03/26/2020 9:00:36 PM
I just want to post a twitter post: (8)
CYDY CytoDyn Inc
03/26/2020 11:25:20 AM
It does seem to happen like this in (1)
CYDY CytoDyn Inc
03/25/2020 4:45:07 PM
I wonder if it is Pestell? (1)
CYDY CytoDyn Inc
03/25/2020 11:35:47 AM
Technically, if the FDA gave their
CYDY CytoDyn Inc
03/24/2020 6:27:31 PM
I heard it also, during the Preside (2)
CYDY CytoDyn Inc
03/20/2020 11:12:24 AM
yup, I did not stay on the wayback
CYDY CytoDyn Inc
03/20/2020 10:39:38 AM
I think I just decided how I'm goin (2)
CYDY CytoDyn Inc
03/20/2020 10:16:02 AM
Going to the way-back machine to re (4)
CYDY CytoDyn Inc
03/20/2020 10:05:27 AM
I have to be honest, The PR firm sh (12)
CYDY CytoDyn Inc
03/19/2020 9:10:04 AM
its in euros, so .96 = $1.04
CYDY CytoDyn Inc
03/18/2020 11:27:53 PM
Yup, and has posted the same tweet
CYDY CytoDyn Inc
03/18/2020 11:19:36 PM
I found this on Twitter: Letting yo
CYDY CytoDyn Inc
03/18/2020 1:35:57 PM
What really gets me about he Covid (1)
CYDY CytoDyn Inc
03/18/2020 1:21:20 PM
My opinion is that doctors who have (6)
CYDY CytoDyn Inc
03/18/2020 12:34:18 PM
Thanks, That helps. Myself and othe
CYDY CytoDyn Inc
03/18/2020 12:01:50 PM
From your perspective, is it fair t
CYDY CytoDyn Inc
03/17/2020 1:48:10 PM
true, guess i'm trying to find an a (2)
CYDY CytoDyn Inc
03/17/2020 1:38:57 PM
You are 100% correct, I'm just poin
CYDY CytoDyn Inc
03/17/2020 1:35:28 PM
you don't think that if leronlimab (1)
CYDY CytoDyn Inc
03/17/2020 1:15:07 PM
because if it does not help, it wou (1)
CYDY CytoDyn Inc
03/17/2020 1:12:35 PM
Lets look at the sequence of events (1)
CYDY CytoDyn Inc
03/17/2020 12:56:29 PM
To elaborate a little more, I would (1)
CYDY CytoDyn Inc
03/17/2020 12:50:06 PM
In yesterday's proactive interview (9)
CYDY CytoDyn Inc
03/16/2020 8:03:48 AM
Can someone more medically educated
CYDY CytoDyn Inc
03/12/2020 10:23:44 AM
It is just stunning what this drug (10)
CYDY CytoDyn Inc
03/03/2020 3:54:56 PM
I have been in this for a very long (1)
CYDY CytoDyn Inc
02/24/2020 11:04:18 AM
Not that you are not wrong, but at
CYDY CytoDyn Inc
02/24/2020 10:57:56 AM
Good point, It could be TBD because
CYDY CytoDyn Inc
02/24/2020 10:35:32 AM
I just looked at the Red Chip web s
CYDY CytoDyn Inc
02/18/2020 10:23:15 AM
I really think the odd thing is tha
CYDY CytoDyn Inc
02/18/2020 7:21:31 AM
It actually says 20+ minutes, what (1)
CYDY CytoDyn Inc
02/08/2020 8:52:36 AM
I tend to agree, I doubt the fda is (2)
CYDY CytoDyn Inc
02/07/2020 10:23:55 PM
It is a very odd headline, more odd
CYDY CytoDyn Inc
01/24/2020 11:06:12 AM
On level 2 I noticed that there rea
CYDY CytoDyn Inc
01/16/2020 4:08:19 PM
You are totally correct, for the lo (1)
CYDY CytoDyn Inc
01/16/2020 3:45:04 PM
This is why there likely was a rush
CYDY CytoDyn Inc
01/10/2020 12:27:37 PM
It is interesting that getting naiv (3)
CYDY CytoDyn Inc
01/10/2020 7:21:10 AM
I heard the same report on the news (1)
Go to page:
  • << First
  • < Previous
  • 12
  • 13
  • Next >

Recent Articles

  • Safe Pro Group Expands Global AI Patent Strategy and Value
  • Kavalan's Historic Triumph at Tokyo Spirits Competition 2025
  • Innovative Solutions in Healthcare Through Quant Blockchain Technology
  • Goodstack Collaborates with TikTok for Global Water Initiative
  • Instylla's Breakthrough Approval for Embrace Hydrogel System
  • RAPT Therapeutics Shares Key Insights from Recent Financial Update
  • Petco's Spooktacular Halloween Collection for Your Pets
  • Izotropic Introduces Innovative Podcast on Breast Imaging Advances
  • Vivos Therapeutics Highlights Silent Threat of Sleep Apnea
  • Super League Plans Earnings Webinar for Q2 2025 Insights
  • Clearinghouse CDFI's $35 Million Equity Raise for Future Growth
  • BrightNight Welcomes Scott Bolton as New VP of External Affairs
  • Ascent Solar: Pioneering Quick Delivery for Space Solar Solutions
  • Star Holdings Reveals Q2 2025 Financial Performance Insights
  • vTv Therapeutics Makes Significant Progress in Diabetes Treatment Trials
  • Oxford Square Capital Corp. Reports Financial Overview for Q2
  • Bionano Genomics Unveils Important Findings on T-ALL in Kids
  • Exciting Launch of Brayden Preserve by LGI Homes in North Carolina
  • Fly-E Group Expands to South America with New Store Launch
  • Replimune's Innovative Progress in Immunotherapy Financial Review
  • Natalia Premovic Joins Playboy's Board for Future Growth
  • Prime Medicine's Financial Results Showcase Strong Growth and Progress
  • GCM Grosvenor Reports Strong Q2 2025 Earnings Growth and Insights
  • Daré Bioscience Unveils Financial Insights and Updates Soon
  • Enviri Corporation Showcases Commitment at Investor Events
  • Ascentage Pharma Plans 2025 Mid-Year Results Release and Update
  • Belite Bio's Direct Offering: What Investors Should Know
  • Insightful Position Updates from Rathbones Group Plc
  • Kinetic Seas Unveils Skilliks: A Game-Changer for AI Software Projects
  • Insights on Apax Global Alpha Limited's Disclosure Position
  • Rathbones Group Plc Reveals Financial Interests in Assura Plc
  • Breadboard Welcomes Nemanja Jokanovic as New Sales VP
  • Victoria's Secret & Co. Announces Upcoming Earnings Call Webcast
  • Trump's New Tariffs: Economic Strategy or Potential Downfall?
  • Genie Energy Reports Strong Q2 2025 Growth and Challenges
  • Transforming Clarence Square: A Green Haven in Downtown
  • Cars.com: Impressive Growth Report for Q2 2025
  • Exciting Enhancements to Clarence Square Park: A Green Oasis
  • Nova Ltd. Delivers Record Financial Results in Second Quarter
  • Join AI Prop's Exciting Global Raffle for Dubai Experience!
  • TEGNA Inc. Delivers Q2 2025 Earnings and Strategic Insights
  • WhiteHorse Finance Reports Q2 Earnings and Confident Outlook
  • Daxor's FDA-Approved Blood Volume Analyzer Revolutionizes Care
  • Sabre Corporation's Strong Q2 2025 Earnings Release Overview
  • FleishmanHillard Elevates Leadership for Global Corporate Affairs
  • Insights from 3 E Network CEO Dr. Yang on Digital Assets
  • Fidelity National Financial Declares Latest Dividend Payment
  • Collegium Pharmaceutical: Second Quarter 2025 Financial Highlights
  • Suburban Propane Partners Reveals Challenges and Insights
  • Cassava Sciences Welcomes Dr. Hulihan as New CMO for Growth
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site